Page last updated: 2024-12-05

1,2,3,4-tetrahydro-1-naphthalenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,2,3,4-Tetrahydro-1-naphthalenol, also known as **1-Tetralol**, is a cyclic alcohol derived from naphthalene. Here's a breakdown of its structure and importance:

**Structure:**

* **Naphthalene:** It's a bicyclic aromatic hydrocarbon with two fused benzene rings.
* **Tetrahydro:** This prefix indicates that four hydrogen atoms have been added to the naphthalene molecule, reducing the aromaticity of the rings.
* **1-Naphthalenol:** This suffix indicates that the hydroxyl group (-OH) is attached to the first carbon atom of the naphthalene core.

**Why it's Important for Research:**

1. **Versatile Precursor:** 1-Tetralol is a key starting material for the synthesis of various pharmaceuticals, agrochemicals, and other organic compounds. Its structural features allow for easy functionalization and modification, making it a valuable building block in organic chemistry.

2. **Pharmacological Activities:** 1-Tetralol itself exhibits some biological activity. It has been reported to have potential as an anti-inflammatory agent and a modulator of certain enzyme activities. However, it's often used as a precursor to synthesize more potent and specific drugs.

3. **Study of Chemical Reactions:** 1-Tetralol's reactivity makes it a model compound for studying various organic reactions, including:
* **Electrophilic Aromatic Substitution:** The partially aromatic nature of the tetralin ring allows for substitutions at specific positions.
* **Oxidation and Reduction:** The hydroxyl group can be easily oxidized or reduced, leading to different derivatives.

4. **Materials Science:** 1-Tetralol derivatives are used in the development of polymers and other materials with specific properties, like light-emitting diodes (LEDs) or sensors.

**Key Points:**

* 1-Tetralol is a versatile compound that can be synthesized into a wide range of valuable products.
* Its importance in research stems from its diverse applications in medicine, materials science, and organic chemistry.

If you're interested in learning more about 1-Tetralol's specific applications or synthesis routes, I recommend searching for scientific literature using keywords like 1-Tetralol synthesis, 1-Tetralol derivatives, or 1-Tetralol biological activity.

1,2,3,4-tetrahydro-1-naphthalenol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10723
CHEMBL ID357784
SCHEMBL ID59026
MeSH IDM0559519

Synonyms (72)

Synonym
HMS1786A14
1-tetralol
529-33-9
wln: l66&tj gq
tetrahydro-1-naphthol
1,3,4-tetrahydro-1-naphthol
1-naphthol,2,3,4-tetrahydro-
nsc5172
nsc-5172
.alpha.-tetralol
1-naphthalenol,2,3,4-tetrahydro-
tetralin-1-ol
1,3,4-tetrahydro-.alpha.-naphthol
5929-35-1
1-naphthol, 1,2,3,4-tetrahydro-
1-naphthalenol, 1,2,3,4-tetrahydro-
1,2,3,4-tetrahydronaphthalen-1-ol
1,2,3,4-tetrahydro-alpha-naphthol
brn 2046227
nsc 5172
ai3-07039
tetrahydro-1-naphthol (van)
1-hydroxytetralin
einecs 208-459-0
1,2,3,4-tetrahydro-1-naphthol
alpha-tetralol
1,2,3,4-tetrahydro-1-naphthol, 97%
CHEMBL357784
ac-alpha-tetralol
T1111
AKOS000120875
NCGC00248522-01
1,2,3,4-tetrahydro-naphthalen-1-ol
cas-529-33-9
dtxsid7027174 ,
tox21_200096
dtxcid607174
NCGC00257650-01
1,2,3,4-tetrahydronaphthol
FT-0640188
unii-87652943hp
3-06-00-02457 (beilstein handbook reference)
87652943hp ,
FT-0622204
FT-0638315
SCHEMBL59026
1-hydroxy-1,2,3,4-tetrahydronaphthalene
1-hydroxytetraline
AKOS016843173
W-105785
1,2,3,4-tetrahydro-1-naphthalenol
1,2,3,4-tetrahydro-.alpha.-naphthol
J6.683D ,
(-)-1,2,3,4-tetrahydro-1-naphthol
(+/-)-.alpha.-tetralol
(+/-)-1,2,3,4-tetrahydro-1-naphthol
(+/-)-1-tetralol
mfcd00063006
1,2,3,4-tetrahydro-1-naphthol, purum, >=97.0% (gc)
mfcd00001739
CS-W004317
SY009329
DS-15486
AMY5940
BB 0323215
1,2,3,4-tetrahydro-1-napthol
Q27269799
SY104799
SB44859
SB44892
EN300-17243
Z56899171
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Sulfotransferase 1A1 Rattus norvegicus (Norway rat)Km30.00005.00007.571410.0000AID39219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID229377Ratio of kcat/Km determined for catalytic efficiency in sulfonation against AST IV2002Journal of medicinal chemistry, Dec-05, Volume: 45, Issue:25
Comparative molecular field analysis of substrates for an aryl sulfotransferase based on catalytic mechanism and protein homology modeling.
AID39219Apparent Michaelis constant (Km) against Arylsulfotransferase (AST IV)2002Journal of medicinal chemistry, Dec-05, Volume: 45, Issue:25
Comparative molecular field analysis of substrates for an aryl sulfotransferase based on catalytic mechanism and protein homology modeling.
AID39220Maximal velocity (Vmax) against Arylsulfotransferase (AST IV)2002Journal of medicinal chemistry, Dec-05, Volume: 45, Issue:25
Comparative molecular field analysis of substrates for an aryl sulfotransferase based on catalytic mechanism and protein homology modeling.
AID624609Specific activity of expressed human recombinant UGT1A62000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.85 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]